Refine by
Abdominal Surgery Articles & Analysis: Older
10 news found
Ltd, today announced they have received clearance from the National Medical Products Administration (NMPA) in China to proceed with their Phase 3 clinical trial to evaluate LB1148 for accelerated return of bowel function in adult patients undergoing bowel/abdominal surgery. This comes shortly after the announcement of the Phase 3 protocol clearance by the U.S. ...
About LB1148 LB1148 is a novel oral liquid formulation of the well-characterized digestive enzyme inhibitor, tranexamic acid (“TXA”), with potential to both reduce abdominal adhesions and help restore bowel function following surgery. ...
” Studies LBS-IST-POI-101 and LBS-POI-201-CN (PROFILE-CN) assessed the efficacy of LB1148 to reduce the formation of adhesions in subjects undergoing abdominal surgery. Study LBS-IST-POI-101 was a Phase 1, single-center, open-label, study enrolling 11 subjects undergoing GI surgery. ...
Adhesions can be found in up to 90% of cases after intra-abdominal surgery. Some patients will suffer life-long complications, and it’s also estimated that the US medical system spends more than $2 billion dollars a year on treating patients with postoperative adhesions,” said Michael Dawson, M.D., Chief Medical Officer, Palisade Bio. “With the ...
GI disorders include inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGID’s).1 GI dysfunctions are also prevalent during recovery from abdominal surgery which can lead to post-operative ileus (POI).2 Current motility technologies are typically limited in scope, invasive and only sample for a ...
These procedures included general surgery, gynecology, urology, colorectal, pediatric, and bariatric surgical cases. ...
The newest ISU features expand upon these capabilities and introduce more advanced features including: 3D measurement, digital tagging, image enhancement, and enhanced camera control based on real-time data from anatomical structures while performing surgery. This will be the first time any of these features will be clinically available in soft-tissue abdominal ...
Sonata is the only fibroid ablation system that does not require incisions or abdominal surgery. Sonata has been uniquely designed to help patients gain access to care through multiple sites of service, supporting rapid adoption around the ...
EO2 Concepts announced today the release of a new, larger wound dressing for post-surgical dehiscence and large, painful leg ulcers. This new 5x7 OxySpur oxygen diffusion dressing is part of the OxyGeni System which provides a complete oxygen therapy and wound monitoring system. Continuous Diffusion of Oxygen (CDO) therapy provides full closure and pain relief to patients dealing with chronic, ...
By reducing procedure time, positively impacting recovery rates and outcomes, and decreasing costs to the healthcare system, Lumendi is expanding options for incisionless therapies to treat conditions that previously required abdominal surgery. Pioneering Endosurgery reflects Lumendi’s innovative, three-part pathway to: expand indication areas and ...